APA (7th ed.) Citation

Zainabadi, K., Vilbrun, S. C., Mathurin, L. D., Walsh, K. F., Pape, J. W., Fitzgerald, D. W., & Lee, M. H. (2024). A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen. The Journal of infectious diseases, 230(2), e447-e456. https://doi.org/10.1093/infdis/jiad564

Chicago Style (17th ed.) Citation

Zainabadi, Kayvan, Stalz Charles Vilbrun, Laurent Daniel Mathurin, Kathleen Frances Walsh, Jean William Pape, Daniel W. Fitzgerald, and Myung Hee Lee. "A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen." The Journal of Infectious Diseases 230, no. 2 (2024): e447-e456. https://doi.org/10.1093/infdis/jiad564.

MLA (9th ed.) Citation

Zainabadi, Kayvan, et al. "A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen." The Journal of Infectious Diseases, vol. 230, no. 2, 2024, pp. e447-e456, https://doi.org/10.1093/infdis/jiad564.